IRONWOOD PHARMACEUTICALS, INC. Accumulated Other Comprehensive Income
IRONWOOD PHARMACEUTICALS, INC. (IRWD) had Accumulated Other Comprehensive Income of -$324.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-06
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$324.00K.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$795.00K.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$1.06M.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$1.71M.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2026-06-30 | -$324.00K 10-Q · filed 2026-08-06 |
| 2026-03-31 | -$795.00K 10-Q · filed 2026-05-07 |
| 2025-12-31 | -$1.06M 10-Q · filed 2026-08-06 |
| 2025-09-30 | -$1.71M 10-Q · filed 2025-11-10 |
| 2025-06-30 | -$2.03M 10-Q · filed 2025-08-11 |
| 2025-03-31 | $294.00K 10-Q · filed 2025-05-12 |
| 2024-12-31 | $923.00K 10-K · filed 2026-02-26 |
| 2024-09-30 | -$2.05M 10-Q · filed 2024-11-07 |
| 2024-06-30 | -$470.00K 10-Q · filed 2024-08-08 |
| 2024-03-31 | -$922.00K 10-Q · filed 2024-05-09 |
| 2023-12-31 | -$3.03M 10-K · filed 2025-03-31 |
| 2023-09-30 | -$752.00K 10-Q · filed 2023-11-09 |
| 2018-09-30 | -$9.00K 10-Q · filed 2018-11-06 |
| 2018-06-30 | -$44.00K 10-Q · filed 2018-08-06 |
| 2018-03-31 | -$91.00K 10-Q · filed 2018-05-04 |
| 2017-12-31 | -$79.00K 10-K · filed 2019-02-25 |
| 2017-09-30 | -$6.00K 10-Q · filed 2017-11-02 |
| 2017-06-30 | -$24.00K 10-Q · filed 2017-08-03 |
| 2017-03-31 | -$41.00K 10-Q · filed 2017-05-08 |
| 2016-12-31 | -$7.00K 10-K · filed 2018-02-22 |
| 2016-09-30 | $61.00K 10-Q · filed 2016-11-07 |
| 2016-06-30 | $39.00K 10-Q · filed 2016-08-08 |
| 2016-03-31 | $29.00K 10-Q · filed 2016-05-10 |
| 2015-12-31 | -$86.00K 10-K · filed 2017-02-22 |
| 2015-09-30 | $48.00K 10-Q · filed 2015-11-05 |
| 2015-06-30 | $22.00K 10-Q · filed 2015-08-07 |
| 2015-03-31 | $3.00K 10-Q · filed 2015-05-06 |
| 2014-12-31 | -$19.00K 10-K · filed 2016-02-19 |
| 2014-09-30 | $25.00K 10-Q · filed 2014-11-05 |
| 2014-06-30 | $3.00K 10-Q · filed 2014-08-05 |
| 2014-03-31 | -$12.00K 10-Q · filed 2014-04-29 |
| 2013-12-31 | $2.00K 10-K · filed 2015-02-18 |
| 2013-09-30 | $19.00K 10-Q · filed 2013-10-28 |
| 2013-06-30 | -$1.00K 10-Q · filed 2013-08-08 |
| 2013-03-31 | $12.00K 10-Q · filed 2013-04-23 |
| 2012-12-31 | $5.00K 10-K · filed 2014-02-07 |
| 2012-09-30 | $7.00K 10-Q · filed 2012-11-06 |
| 2012-06-30 | -$9.00K 10-Q · filed 2012-08-07 |
| 2012-03-31 | $3.00K 10-Q · filed 2012-05-10 |
| 2011-12-31 | $6.00K 10-K · filed 2013-02-21 |
| 2011-09-30 | $6.00K 10-Q · filed 2011-11-09 |
| 2011-06-30 | $53.00K 10-Q · filed 2011-08-12 |
| 2010-12-31 | $1.00K 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |